Paradigm Strategies in Wealth Management’s Bio-Techne TECH Stock Holding History

Paradigm Strategies in Wealth Management’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-3,625	Closed	-$213K	–	54
2025 Q1	$213K	Hold	3,625	–	–	0.14%	50
2024 Q4	$261K	Hold	3,625	–	–	0.17%	42
2024 Q3	$290K	Hold	3,625	–	–	0.18%	39
2024 Q2	$260K	Hold	3,625	–	–	0.16%	40
2024 Q1	$255K	Sell	3,625 -748	-17%	-$53.5K	0.16%	43
2023 Q4	$337K	Hold	4,373	–	–	0.22%	34
2023 Q3	$298K	Hold	4,373	–	–	0.19%	39
2023 Q2	$357K	Hold	4,373	–	–	0.24%	29
2023 Q1	$324K	Hold	4,373	–	–	0.26%	31
2022 Q4	$362K	Sell	4,373 -171	-4%	-$13.6K	0.32%	26
2022 Q3	$323K	Sell	4,544 -288	-6%	-$24.9K	0.29%	28
2022 Q2	$419K	Hold	4,832	–	–	0.46%	25
2022 Q1	$523K	Hold	4,832	–	–	0.55%	23
2021 Q4	$625K	Hold	4,832	–	–	0.63%	20
2021 Q3	$585K	Hold	4,832	–	–	0.55%	23
2021 Q2	$544K	Hold	4,832	–	–	0.49%	24
2021 Q1	$461K	Buy	+4,832	New	+$441K	0.45%	26

Other funds holding TECH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Paradigm Strategies in Wealth Management's TECH Position: Q2 2025 in Review

Paradigm Strategies in Wealth Management sold out of Bio-Techne (TECH) in Q2 2025, closing a stake of 3,625 shares — an estimated $213K sold.

Paradigm Strategies in Wealth Management first reported a position in TECH in Q1 2021 and held it in 17 quarters. The position peaked at $625K in Q4 2021. 555 funds tracked by Wall St. Rank hold TECH as of Q2 2025.

Paradigm Strategies in Wealth Management reported no remaining Bio-Techne position as of Q2 2025 after selling out during the quarter.
Paradigm Strategies in Wealth Management sold 3,625 Bio-Techne shares in Q2 2025, an estimated $213K.
Paradigm Strategies in Wealth Management first reported a position in Bio-Techne in Q1 2021 and held it in 17 quarters.
Paradigm Strategies in Wealth Management's Bio-Techne position peaked at $625K in Q4 2021.
555 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2025.

Based on Paradigm Strategies in Wealth Management's 13F filing for Q2 2025, filed 1 Aug 2025.